SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form 10-Q/A
X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended February 29, 1996
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from to
Commission File Number 0-3997
GERIATRIC & MEDICAL COMPANIES, INC.
(Exact Name of Registrant as Specified in the Charter)
Delaware 23-1713341
(State or other jurisdiction (IRS Employer Identification
of incorporation or organization) Number)
5601 Chestnut Street, Philadelphia, Pennsylvania 19139
(Address of Principal Executive Offices) (zip code)
(215) 476-2250
(Registrant's telephone number, including area code)
N/A
Former name, former address and former fiscal year,
if changed since last report
Indicate by check mark whether the registant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes X No
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
On April 12, 1996, there were 15,429,600 shares of common stock, $.10
par value outstanding.
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GERIATRIC & MEDICAL COMPANIES, INC.
July 9, 1996 By: James J. O'Malley
Vice President and
Chief Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
(Replace this text with the legend)
</LEGEND>
<MULTIPLIER> 1<F2>
<CURRENCY> 0
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> MAY-31-1996
<PERIOD-START> JUN-01-1995
<PERIOD-END> FEB-29-1996
<EXCHANGE-RATE> 1
<CASH> 592,000
<SECURITIES> 0
<RECEIVABLES> 70,914,000
<ALLOWANCES> 13,726,000
<INVENTORY> 4,457,000
<CURRENT-ASSETS> 72,914,000
<PP&E> 155,548,000
<DEPRECIATION> 65,105,000
<TOTAL-ASSETS> 188,486,000
<CURRENT-LIABILITIES> 40,191,000
<BONDS> 0
0
0
<COMMON> 1,543,000
<OTHER-SE> 16,874,000
<TOTAL-LIABILITY-AND-EQUITY> 188,486,000
<SALES> 148,101,000
<TOTAL-REVENUES> 148,101,000
<CGS> 0
<TOTAL-COSTS> 129,494,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 5,277,000
<INTEREST-EXPENSE> 8,577,000
<INCOME-PRETAX> 4,753,000
<INCOME-TAX> 1,096,000
<INCOME-CONTINUING> 3,657,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,657,000
<EPS-PRIMARY> .24
<EPS-DILUTED> 0
<FN>
